Bibliographie
Retrouvez ici les sources et recommandations qui ont servi de base scientifique à ce projet.
  1. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the Task Force on the Management of Elevated Blood Pressure and Hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024 Sep;45(35):ehae178. doi: 10.1093/eurheartj/ehae178.
    Disponible sur: https://dx.doi.org/10.1093/eurheartj/ehae178
  2. Bress AP, Anderson TS, Flack JM, Ghazi L, Hall ME, Laffer CL, et al. The management of elevated blood pressure in the acute care setting: A scientific statement from the American Heart Association. Hypertension. 2024 Aug;81(8):e94-106. doi: 10.1161/HYP. 0000000000000255.
  3. McCarthy CP, Bruno RM, Rahimi K, Touyz RM, McEvoy JW. What is new and different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension? Hypertension [Internet]. 2024;83(2):e24173. [cité 15 sept 2025].
    Disponible sur: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.24173
  4. De Backer G, Demeure F, Descamps O, De Bacquer D. SCORE2 : la nouvelle table pour évaluer le risque de maladie cardiovasculaire. Rev Med Liège. 2021;76(7-8):460-464.
  5. Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res. 2014 Jun;37(6):565-572. doi: 10.1038/hr.2014.58.
  6. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH), endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023 Dec;41(12):1874-2071. doi: 10.1097/HJH. 0000000000003715.
  7. Medovchshikov V, Tlegenova ZS, Yeshniyazov N. New ESC guidelines on hypertension: key messages. Heart Vessels Transplant [Internet]. 2024 Jul 30 [cité 16 sept 2025];8(4).
    Disponible sur: https://hvt-journal.com/articles/art524
  8. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
  9. Kario K. Management of hypertension in the digital era. Hypertension. 2020 Sep;76(3):640-650. doi: 10. 1161/HYPERTENSIONAHA.120.14658.
  10. SEC Working Group for the 2024 ESC guidelines for the management elevated blood pressure and hypertension and SEC Guidelines Committee. Comments on the 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Rev Esp Cardiol Engl Ed. 2025 Apr 1;78(4):296-300. doi: 10.1016/j.rec.2024. 11.018.
  11. Benetos A, Temmar M, Safar M. Rigidité artérielle, pression pulsée et risque cardio-vasculaire. Médecine Maghreb. 2001;92:9-12.
  12. Laty D. Inhibiteurs calciques : tout savoir sur ces anti-hypertenseurs. Santé Magazine [Internet]. 2023 Jun 1 [cité 2025 Sept 16].
    Disponible sur: https://www.santemagazine.fr/sante/maladies/maladies-cardiovasculaires/hypertension/inhibiteurs-calciques-tout-savoir-sur-ces-anti-hypertenseurs-1023795
  13. Kravitz L. Exercise and resting BP [Internet]. [cité 2025 Oct 20].
    Disponible sur: https://www.unm.edu/~lkravitz/Article%20folder/restingbp.html
  14. Laukkanen JA, Kurl S. Blood pressure responses during exercise testing—is up best for prognosis? Ann Med. 2012;44(3):218-24. doi: 10.3109/07853890.2011.560180.
  15. GE HealthCare (United States). Blood Pressure Response During Exercise Stress Testing [Internet]. 2024 Mar 11 [cité 2025 Oct 20].
    Disponible sur: https://www.gehealthcare.com/insights/article/blood-pressure-response-during-exercise-stress-testing
  16. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023 Dec;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480.
  17. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015 Nov 1;36(41):2793-867. doi: 10.1093/eurheartj/ehv316.
  18. Tang A, Yang E, Ebinger JE. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More? Curr Hypertens Rep. 2024;26(1):21-30. doi: 10.1007/s11906-023-01273-1.
  19. Amekran Y, El hangouche AJ. Effects of Exercise Training on Heart Rate Variability in Healthy Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Cureus. 2024 Jun 16;16(6):e62465. doi: 10.7759/cureus.62465.
  20. Jiang H, Yu Z, Liu J, Zhang W. Bedtime administration of antihypertensive medication can reduce morning blood pressure surges in hypertensive patients: a systematic review and meta-analysis. Ann Palliat Med. 2021 Jun;10(6):6841-9. doi: 10.21037/apm-21-1405.
  21. Kim HJ, Jo SH. Nighttime administration of antihypertensive medication: a review of chronotherapy in hypertension. Korean J Intern Med. 2024 Mar 1;39(2):205-14. doi: 10.3904/kjim.2023.304.
  22. Xie Z, Zhang J, Wang C, Yan X. Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2021 Jun 4;21(1):274. doi: 10.1186/s12872-021-02081-3.
  23. Yano Y, Kim HC, Lee H, Azahar N, Ahmed S, Kitaoka K, et al. Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Pro Side of the Argument. Hypertension. 2022 Aug;79(8):1563-70. doi: 10.1161/HYPERTENSIONAHA. 122.18459.
  24. Lempiäinen PA, Ylitalo A, Huikuri H, Kesäniemi YA, Ukkola OH. Non-dipping blood pressure pattern is associated with cardiovascular events in a 21-year follow-up study. J Hum Hypertens. 2024 May;38(5):444-51. doi: 10. 1038/s41371-024-00909-2.
  25. Shiina K. Obstructive sleep apnea-related hypertension: a review of the literature and clinical management strategy. Hypertens Res. 2024 Nov;47(11):3085-98. doi: 10. 1038/s41440-024-01852-y.
  26. Kario K, Williams B. Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments. Hypertension. 2021 Sep;78(3):564-77. doi: 10.1161/HYPERTENSIONAHA. 121.17440.
  27. Vemu PL, Yang E, Ebinger JE. 2023 ESH Hypertension Guideline Update: Bringing Us Closer Together Across the Pond. American College of Cardiology [Internet]. 2024 Feb 5 [cité 2025 Aug 28].
    Disponible sur: https://www. acc.org/Latest-in-Cardiology/Articles/2024/02/05/11/43/2023-ESH-Hypertension-Guideline-Update
  28. Khalil H, Zeltser R. Antihypertensive Medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan- [mis à jour 2023 May 8; cité 2025 Sept 16].
    Disponible sur: http://www.ncbi.nlm. nih.gov/books/NBK554579/
  29. Abuhasira R, Burrack N, Turjeman A, Patt YS, Leibovici L, Grossman A. Comparative analysis of first-line antihypertensive treatment classes. Am J Med. 2025 Mar;138(3):449-457. e7. doi: 10.1016/j.amjmed.2024.10.016.
  30. Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018 Jun 1;39(21):1883-948. doi: 10.1093/eurheartj/ehy037.
  31. Huang QF, Yang WY, Asayama K, Zhang ZY, Thijs L, Li Y, et al. Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension. Hypertension. 2021 Feb;77(2):254-64. doi: 10.1161/HYPERTENSIONAHA. 120.14591.
  32. Cluett JL, William JH. Evaluation and Management of Resistant Hypertension: Core Curriculum 2024. Am J Kidney Dis. 2024 Sep;84(3):374-87. doi: 10.1053/j.ajkd.2024.04.009.
  33. Ou YH, Tan A, Lee CH. Management of hypertension in obstructive sleep apnea. Am J Prev Cardiol. 2023 Mar;13:100475. doi: 10.1016/j.ajpc.2023.100475.
  34. Fujishima S, Abe I, Kaseda S, Koga T, Hirano H, Hamada T, et al. Ambulatory Blood Pressure Monitoring in Diagnosing a Pheochromocytoma of the Urinary Bladder: A Case Report. Angiology. 1997 Jul;48(7):655-8. doi: 10.1177/000331979704800714.
  35. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
  36. Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014 Jun 1;99(6):1915-42. doi: 10.1210/jc.2014-1498.
  37. Memon S, Srivastava P, Karlekar M, Thakkar H, Bandgar T. Ambulatory blood pressure monitoring in pheochromocytoma – paragangLia: A single center experience. J Postgrad Med. 2024;70(2):84-90. doi: 10. 4103/jpgm.jpgm_208_23.